Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated - KIVIRID

Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated

Authors: Juan Tamargo, Stefan Agewall

Published: 2023-10-20

DOI: 10.1093/eurheartj/ehad660

Source: Full article

Abstract

No abstract found.